Conference abstract
Research articlePublished 2011
Statistical Issues in Bioavailability/Bioequivalence Studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For the approval of generic drug products, bioavailability/bioequivalence studies are often conducted to demonstrate that the drug absorption profiles in terms of the extent and rate of absorption of test products are bioequivalent to those of the innovative drug product. The bioavailability/bioequivalence studies are often conducted under a standard two-sequence, two-period (2x2) crossover design. Under the standard 2x2 crossover design, statistical methods are well established for the assessment of bioequivalence. However, it is a concern whether approved generic drug products can be used safely and interchangeably. In this article, drug interchangeability under a replicated crossover bioavailability/bioequivalence study is discussed. Several controversial statistical issues that are commonly encountered in the assessment of bioequivalence are discussed. In addition, some frequently asked questions during regulatory submissions are reviewed. Recommendations regarding possible resolutions are made whenever possible. Some concluding remarks on the feasibility of the application of current methods for bioequivalence to the assessment of biosimilarity of follow-on biologics are also presented.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2014
Bioavailability and Bioequivalence Issues Associated With Oral Anticancer Drugs and Effect on Drug Market
Conference abstract
Advanced discussions of the current issues and analyzing the novel approaches of bioavailability and bioequivalence
Research article · 2011
Current Issues on Bioavailability and Bioequivalence Determination
Article · 29 Aug 2025
Clinical Pharmacology A Pillar for Bioequivalence and Bioavailability Studies
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shein-Chung Chow”
- BylineArticles whose byline prints “Laszlo Endrenyi”
- BylineArticles whose byline prints “Eric Chi”
- BylineArticles whose byline prints “Lan-Yan Yang”
- BylineArticles whose byline prints “Laszlo Tothfalusi”
